Combat Stress
Leatherhead, KT22 0BX, United Kingdom
NCT Number: NCT06905158
The prevalence of tinnitus in military veterans is notably higher than the non-veteran population and can significantly disrupt the lives of veterans. Given the profound impact of tinnitus on the lives of veterans, along with the considerable economic burden and barriers to treatment, it is crucial to explore the feasibility of new approaches. Wearable sound technologies offer a non-invasive and easily accessible approach. As such, this waitlist-controlled trial aims to assess the efficacy of this new non-invasive white noise wearable device in reducing tinnitus symptoms between baseline and the one-month post-randomisation among veterans who have experienced tinnitus for at least three months.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Leatherhead, KT22 0BX, United Kingdom
The presence of tinnitus has been significantly associated with depression, anxiety, sleep difficulties and job performance in addition to poorer general physical health.. However, to our knowledge, there is currently no intervention for tinnitus that is supported as effective for most people. As such, there is a need to explore alternative approaches. Sound therapy offers an easily accessible, non-invasive, low-cost option. As such, this study aims to explore the effectiveness of a non-invasive white noise device in reducing symptoms of tinnitus and mental health difficulties in military veterans. A total of 20 military veterans who have self-reported experiencing tinnitus for at least three months will be recruited. : In this waitlist-controlled trial, the tinnitus device will be compared to the waitlist-controlled group who will receive the device one-month post-randomisation. The trial will be conducted in a veteran population (n = 20) that was recruited from a prior study that had aimed to explore the impact of tinnitus on wellbeing within a veteran population. Once the participants receive the tinnitus device, they will be asked to use the device for a period of one month. The primary outcome is the change in self-reported tinnitus symptoms and mental health difficulties between baseline (day 0) and the one-month post-randomisation (day 28). The outcome variables of interest will be assessed at all timepoints (baseline, one-month post-randomisation, and two-months post-randomisation) and the predictor variables will only be assessed at baseline to reduce participant burden. It is hypothesised that the non-invasive device will result in significant reductions in symptoms of tinnitus (as indicated using the TFI) and mental health difficulties (as measured using the gHQ-12) from baseline to one-month post-intervention in comparison to a waitlist control.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: TinniSoothe, Non-invasive white noise device, Tinnitus sound device
Time frame: [Time Frame: Change from baseline TFI score at one-month post-randomisation and two-months post-randomisation]
Scores range from 0-250, with higher scores indicating greater tinnitus symptoms
Time frame: [Time Frame: Change from baseline General Health Questionnaire-12 score at one-month post-randomisation and two-months post-randomisation]
Scores range from 0-36, with higher scores indicating greater psychological distress
Time frame: [Time Frame: Change from baseline SWLS score at one-month post-randomisation and two-months post-randomisation]
Scores range from 5-35, with a higher score indicating greater life satisfaction.
Time frame: [Time Frame: Change from baseline ISI score at one-month post-randomisation and two-months post-randomisation]
Scores range from 0-28, with a higher score indicating greater insomnia severity.
Time frame: [Time Frame: Predictor variable]
A 4-item measure of the presence of PTSD symptoms according to the Diagnostic and Statistical Manual of Mental Disorders-IV. Scores range from 0-16, with a higher score indicating more severe PTSD
Time frame: [Time Frame: Predictor variable]
Scores range from 0-30, with higher scores indicating greater severity of physical health and somatic symptoms
Time frame: [Time Frame: Consenting participants will be contacted at one-month post-randomisation for the immediate intervention group and two-months post-randomisation for the waitlist control group]
Consenting participants will be contacted at one-month post-randomisation for the immediate intervention group and two-months post-randomisation for the waitlist control group
Time frame: [Time Frame: Intervention end (approximately 1 year)]
Feasibility endpoint
Time frame: [Time Frame: Study end (approximately 1 year)]
Feasibility endpoint
Time frame: [Time Frame: Study end (approximately 1 year)]
Safety endpoint, calculated as total number of adverse events reported across the study. Adverse events as defined in the study protocol. Adverse events will be reported in the qualitative questionnaire post-intervention.
Combat Stress
Other
Evaluating the Effectiveness of a Non-invasive Tinnitus Device in Reducing Symptoms of Tinnitus and Mental Health Difficulties in Military Veterans: A Pilot Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731230
Ear Diseases, Hearing Disorders
Istanbul, Kadikoy, Turkey (Türkiye)
View Trial DetailsNCT04661995
Ear Diseases, Hearing Disorders
Durham, North Carolina, United States
View Trial DetailsNCT07637708
Ear Diseases, Hearing Disorders
Santiago, Chile
View Trial DetailsNCT07631403
Ear Diseases, Hearing Disorders
Ankara, Turkey (Türkiye)
View Trial Details